NEWS.
The ERC Starting Grants are among the most highly regarded and competitive research grants for young research group leaders in Europe. This year 494 researchers across different disciplines were selected out of 3,474 proposals.
Dr. Hannah Uckelmann is among this years awardees is for her project “EpiTransformers”, which aims to explore the epigenetic processes responsible for driving the development of leukemia. Her ERC project specifically investigates components of the nuclear export machinery that are hijacked by cancer cells to drive oncogenic gene expression programs. The ultimate goal of Dr. Uckelmanns research is to elucidate the chromatin complexes that are essential to leukemia cells and thereby improve our understanding of disease biology.
ERC Starting Grant!
Rhein-Main Cancer Retreat 2024
Posters by Sara, Arezo and Hannah!
Frankfurt Cancer Conference, 2024
EHA Meeting 2024
Madrid, 2024
Hannah was accepted to join the EHA-ASH Translational Research Training in Hematology
TRTH is a year-long training and mentoring program for early career researchers transitioning to independence.
Find out more:
https://ehaweb.org/research/research-trainings/eha-ash-translational-research-training-in-hematology/
Hannah travels to Japan to give the keynote in Kumamoto for the 21st IRCMS Symposium on The Dynamics and Development of Normal and Malignant Hematopoietic Stem Cells on Feb. 20-21, 2024. Thank you Goro Sashida for the invitation!
Hannah receives Max-Eder Junior Research Group funding!
The Uckelmann lab receives highly competitive junior research group funding from the German Cancer Aid (Deutsche Krebshilfe). Her Max-Eder group will explore the epigenetic network of mutant NPM1 in acute myeloid leukemia.
Find out more:
